Details of participants
| Participants | |
| n=56 | |
| Role in relation to guidelines | |
| Guideline developers | 35 |
| Researchers | 16 |
| Patient and public representatives | 5 |
| Country (n=14) | |
| Australia | 3 |
| Belgium | 2 |
| Canada | 5 |
| Czech Republic | 3 |
| Finland | 5 |
| France | 6 |
| Germany | 3 |
| Japan | 4 |
| The Netherlands | 8 |
| New Zealand | 2 |
| Norway | 5 |
| Spain | 4 |
| UK | 3 |
| USA | 3 |